Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.21 | N/A |
| PEG Ratio (TTM) | -1.01 | N/A |
| P/S Ratio (TTM) | 14.78 | N/A |
| P/B Ratio (TTM) | 0.89 | N/A |
| P/FCF Ratio (TTM) | 7.47 | N/A |
| Price to 5YR AVG Earnings Ratio | 69.18 | N/A |
| Price to 5YR AVG FCF Ratio | 7.86 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.30% | N/A |
| ROE (TTM) | 3.25% | N/A |
| Net Profit Margin (TTM) | 54.31% | N/A |
| ROIC 5YR AVG | 3.54% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.99% | 91.02% | 121.58% |
| Revenue | -10.54% | 86.23% | 157.29% |
| Net Income | -1.66% | 91.28% | 122.02% |
| Cash Flow | 17.83% | 110.26% | 103.96% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.80 | N/A |
| Quick Ratio (TTM) | 1.80 | N/A |
| D/E Ratio (TTM) | 0.41 | N/A |
| Interest Coverage (TTM) | 5.54 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.27 | N/A |
| LTL to 5YR AVG FCF | 3.63 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.41% | N/A |